Boost to NIA/NIH Funding: The omnibus federal spending deal, currently being considered by Congress, will deliver a $414 million funding increase for Alzheimer’s disease research at the National Institutes of Health (NIH).The spending deal will also enact Kevin and Avonte’s Law, which will deliver $10 million in federal funding over the next 5 years to support public safety programs that enable first responders to quickly locate individuals with Alzheimer’s or autism who wander away from their caregivers.
This spending package takes important steps forward in funding the fight against Alzheimer’s and helping the over 5 million Americans living with dementia and their family caregivers. “Enacting Kevin and Avonte’s law will protect our nation’s most vulnerable families from the hazards of wandering, which is a very common and dangerous behavior among individuals with Alzheimer’s. The deadline to achieve the primary goal of the national Alzheimer’s plan—to find a cure or more efficacious treatment by 2025— is fast approaching.
Read the Full Story at www.econotimes.com
AFA: How Federal Spending Deal Impacts Individuals with Alzheimer’s
More from Current EventMore posts in Current Event »
- Failure of once-promising Alzheimer’s drug reinforces doubts about amyloid beta | Med City News
- Former NFL Wife on Her Husband’s Battle with CTE
- Capito, Collins introduce bill to increase awareness of Alzheimer’s services | Ripon Advance
- ‘Young Blood’ Researchers Are Still in the Pursuit to Stall Aging, Slow Alzheimer’s | Being Patient
- ‘It is not alarmist to say that the people of Florida are being slowly poisoned by the water’ | Opinion | Miami Herald